|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Solomon E, Borrow J and Goddard AD:
Chromosome aberrations and cancer. Science. 254:1153–1160. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takada H, Imoto I, Tsuda H, Sonoda I,
Ichikura T, Mochizuki H, Okanoue T and Inazawa J: Screening of DNA
copy-number aberrations in gastric cancer cell lines by array-based
comparative genomic hybridization. Cancer Sci. 96:100–110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hidaka S, Yasutake T, Kondo M, Takeshita
H, Yano H, Haseba M, Tsuji T, Sawai T, Nakagoe T and Tagawa Y:
Frequent gains of 20q and losses of 18q are associated with lymph
node metastasis in intestinal-type gastric cancer. Anticancer Res.
23:3353–3357. 2003.PubMed/NCBI
|
|
6
|
Oga A, Kong G, Ishii Y, Izumi H, Park CY
and Sasaki K: Preferential loss of 5q14-21 in intestinal-type
gastric cancer with DNA aneuploidy. Cytometry. 46:57–62. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kokkola A, Monni O, Puolakkainen P,
Larramendy ML, Victorzon M, Nordling S, Haapiainen R, Kivilaakso E
and Knuutila S: 17q12-21 amplicon, a novel recurrent genetic change
in intestinal type of gastric carcinoma: A comparative genomic
hybridization study. Genes Chromosomes Cancer. 20:38–43. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu MS, Chang MC, Huang SP, Tseng CC, Sheu
JC, Lin YW, Shun CT, Lin MT and Lin JT: Correlation of histologic
subtypes and replication error phenotype with comparative genomic
hybridization in gastric cancer. Genes Chromosomes Cancer.
30:80–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwon MJ, Kim RN, Song K, Jeon S, Jeong HM,
Kim JS, Han J, Hong S, Oh E, Choi JS, et al: Genes co-amplified
with ERBB2 or MET as novel potential cancer-promoting genes in
gastric cancer. Oncotarget. 8:92209–92226. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tabach Y, Kogan-Sakin I, Buganim Y,
Solomon H, Goldfinger N, Hovland R, Ke XS, Oyan AM, Kalland KH,
Rotter V and Domany E: Amplification of the 20q chromosomal arm
occurs early in tumorigenic transformation and may initiate cancer.
PLoS One. 6:e146322011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garcia-Murillas I, Sharpe R, Pearson A,
Campbell J, Natrajan R, Ashworth A and Turner NC: An siRNA screen
identifies the GNAS locus as a driver in 20q amplified breast
cancer. Oncogene. 33:2478–2486. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sana M and Malik HJ: Current and emerging
breast cancer biomarkers. J Cancer Res Ther. 11:508–513. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ptashkin RN, Pagan C, Yaeger R, Middha S,
Shia J, O'Rourke KP, Berger MF, Wang L, Cimera R, Wang J, et al:
Chromosome 20q amplification defines a subtype of microsatellite
stable, left-sided colon cancers with wild-type RAS/RAF and better
overall survival. Mol Cancer Res. 15:708–713. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sillars-Hardebol AH, Carvalho B, Belien
JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA,
Ponten F, Fijneman RJ and Meijer GA: BCL2L1 has a functional role
in colorectal cancer and its protein expression is associated with
chromosome 20q gain. J Pathol. 226:442–450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hodgson JG, Chin K, Collins C and Gray JW:
Genome amplification of chromosome 20 in breast cancer. Breast
Cancer Res Treat. 78:337–345. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Snijders AM and Mao JH: Multi-omics
approach to infer cancer therapeutic targets on chromosome 20q
across tumor types. Adv Mod Oncol Res. 2:215–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scotto L, Narayan G, Nandula SV,
Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright
JD, Pothuri B, Mansukhani M and Murty VV: Identification of copy
number gain and overexpressed genes on chromosome arm 20q by an
integrative genomic approach in cervical cancer: Potential role in
progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bolha L, Ravnik-Glavac M and Glavac D:
Long noncoding RNAs as biomarkers in cancer. Dis Markers.
2017:72439682017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng S, Xie X, Xiao YF, Tang B, Hu CJ,
Wang SM, Wu YY, Dong H, Li BS and Yang SM: Long noncoding RNA
LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress
gastric cancer progression. Cancer Lett. 412:179–187. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan L, Liang W, Fu M, Huang ZH, Li X,
Zhang W, Zhang P, Qian H, Jiang PC, Xu WR and Zhang X:
Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes
gastric cancer progression. J Cancer Res Clin Oncol. 143:991–1004.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Chen Z, Fan R, Jiang B, Chen X,
Chen Q, Nie F, Lu K and Sun M: Over-expressed long noncoding RNA
HOXA11-AS promotes cell cycle progression and metastasis in gastric
cancer. Mol Cancer. 16:822017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Forrest ME and Khalil AM: Review:
Regulation of the cancer epigenome by long non-coding RNAs. Cancer
Lett. 407:106–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
ENCODE Project Consortium, ; Birney E,
Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH,
Weng Z, Snyder M, Dermitzakis ET, et al: Identification and
analysis of functional elements in 1% of the human genome by the
ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qi F, Liu X, Wu H, Yu X, Wei C, Huang X,
Ji G, Nie F and Wang K: Long noncoding AGAP2-AS1 is activated by
SP1 and promotes cell proliferation and invasion in gastric cancer.
J Hematol Oncol. 10:482017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
YiRen H, YingCong Y, Sunwu Y, Keqin L,
Xiaochun T, Senrui C, Ende C, XiZhou L and Yanfan C: Long noncoding
RNA MALAT1 regulates autophagy associated chemoresistance via
miR-23b-3p sequestration in gastric cancer. Mol Cancer. 16:1742017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thorvaldsen JL, Duran KL and Bartolomei
MS: Deletion of the H19 differentially methylated domain results in
loss of imprinted expression of H19 and Igf2. Genes Dev.
12:3693–3702. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chu C, Zhang QC, da Rocha ST, Flynn RA,
Bharadwaj M, Calabrese JM, Magnuson T, Heard E and Chang HY:
Systematic discovery of Xist RNA binding proteins. Cell.
161:404–416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nasrollahzadeh-Khakiani M, Emadi-Baygi M,
Schulz WA and Nikpour P: Long noncoding RNAs in gastric cancer
carcinogenesis and metastasis. Brief Funct Genomics. 16:129–145.
2017.PubMed/NCBI
|
|
35
|
Sun M, Nie FQ, Wang ZX and De W:
Involvement of lncRNA dysregulation in gastric cancer. Histol
Histopathol. 31:33–39. 2016.PubMed/NCBI
|
|
36
|
Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ and
Cheng XD: Long non-coding RNAs towards precision medicine in
gastric cancer: Early diagnosis, treatment, and drug resistance.
Mol Cancer. 19:962020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Zhang YM, Ma FB, Pan SR and Liu BZ:
Long noncoding RNA HOXA11-AS promotes gastric cancer cell
proliferation and invasion via SRSF1 and functions as a biomarker
in gastric cancer. World J Gastroenterol. 25:2763–2775. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Deng W, Zhang Y, Cai J, Zhang J, Liu X,
Yin J, Bai Z, Yao H and Zhang Z: LncRNA-ANRIL promotes gastric
cancer progression by enhancing NF-kB signaling. Exp Biol Med
(Maywood). 244:953–959. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu K, Ren Q and Zhao Y: lncRNA MALAT1
overexpression promotes proliferation, migration and invasion of
gastric cancer by activating the PI3K/AKT pathway. Oncol Lett.
17:5335–5342. 2019.PubMed/NCBI
|
|
40
|
Ma JX, Yang YL, He XY, Pan XM, Wang Z and
Qian YW: Long noncoding RNA MNX1-AS1 overexpression promotes the
invasion and metastasis of gastric cancer through repressing
CDKN1A. Eur Rev Med Pharmacol Sci. 23:4756–4762. 2019.PubMed/NCBI
|
|
41
|
Hu B, Wang X and Li L: Long noncoding RNA
LINC00337 promote gastric cancer proliferation through repressing
p21 mediated by EZH2. Am J Transl Res. 11:3238–3245.
2019.PubMed/NCBI
|
|
42
|
Li D, Chen Y, Mei H, Jiao W, Song H, Ye L,
Fang E, Wang X, Yang F, Huang K, et al: Ets-1 promoter-associated
noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric
cancer progression. Oncogene. 37:4871–4886. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nicolet C, Guerin E, Neuville A, Kerckaert
JP, Wicker N, Bergmann E, Brigand C, Kedinger M, Gaub MP and Guenot
D: Evidence for various 20q status using allelotyping, CGH arrays,
and quantitative PCR in distal CIN colon cancers. Cancer Lett.
282:195–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tanikawa C, Kamatani Y, Toyoshima O,
Sakamoto H, Ito H, Takahashi A, Momozawa Y, Hirata M, Fuse N,
Takai-Igarashi T, et al: Genome-wide association study identifies
gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21.
Cancer Sci. 109:4015–4024. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jang SH, Park JW, Kim HR, Seong JK and Kim
HK: ADRM1 gene amplification is a candidate driver for metastatic
gastric cancers. Clin Exp Metastasis. 31:727–733. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ,
Hsu CW, Chen WS and Wang JH: Linc00659, a long noncoding RNA, acts
as novel oncogene in regulating cancer cell growth in colorectal
cancer. Mol Cancer. 17:722018. View Article : Google Scholar : PubMed/NCBI
|
